Share ownership Thermo Fisher Scientific, Inc.

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2026-04-10 pm EDT			5-day change	1st Jan Change
496.11 ^USD	-0.87%		+0.95%	-14.38%

Apr. 10	Bio-Works nominates two new board members	FW
Apr. 09	Seer, Inc. and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 Precise Sg100k Samples	CI

Share class: Thermo Fisher Scientific, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	443,676,411	381,808,629 ( 86.06 %)	61,176,146 ( 13.79 %)	86.06 %

Major shareholders: Thermo Fisher Scientific, Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.085 %	34,133,702	9.085 %	17 787 M $
BlackRock Advisors LLC 5.558 %	20,883,304	5.558 %	10 882 M $
STATE STREET CORPORATION 4.422 %	16,613,761	4.422 %	8 658 M $
Eaton Vance Management 3.166 %	11,894,277	3.166 %	6 198 M $
Capital Research & Management Co. (World Investors) 2.929 %	11,003,814	2.929 %	5 734 M $
Fidelity Management & Research Co. LLC 2.605 %	9,787,642	2.605 %	5 100 M $
Geode Capital Management LLC 2.182 %	8,196,477	2.182 %	4 271 M $
T. Rowe Price International Ltd. 2.05 %	7,701,353	2.05 %	4 013 M $
BlackRock Life Ltd. 1.933 %	7,261,510	1.933 %	3 784 M $
JPMorgan Investment Management, Inc. 1.76 %	6,611,878	1.76 %	3 446 M $
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Western Asset Management Company DTVM Ltda. 0.0021 %	379,241	0.0021 %	4 M $
Safra Asset CTVM SA (Investment Management) 0.00024 %	43,300	0.00024 %	468 348 $

Breakdown by shareholder type

Institutional	73.69%
Other	12.06%
State Street Corp.	4.42%
Swedbank AB	0.45%
Manulife Financial Corp.	0.41%
Sumitomo Mitsui Trust Group, Inc.	0.29%
Schweizerische Nationalbank	0.28%
Rathbones Group Plc	0.25%
Governments	0.14%
Individuals	0.12%
Fifth Third Bancorp	0.09%
Menora Mivtachim Holdings Ltd.	0.08%
Skandinaviska Enskilda Banken AB	0.07%
SEI Investments Co.	0.07%
Danske Bank A/S	0.07%
The Bank of Nova Scotia	0.03%
Regions Financial Corp.	0.02%
Polar Capital Holdings Plc	0.02%
Münchener Rückversicherungs-Gesellschaft AG	0.02%
Zurich Insurance Group AG	0.02%
Markel Group, Inc.	0.02%
Commerzbank AG	0.02%
Silvercrest Asset Management Group, Inc.	0.02%
Peapack-Gladstone Financial Corp.	0.01%
Associated Banc-Corp	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Univest Financial Corp.	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
The Allstate Corp.	0.01%
ING Groep NV	0.01%
Unknown	7.28%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	61.45%
United Kingdom	12.54%
Canada	5.02%
Germany	2.11%
Norway	1.63%
Switzerland	1.41%
France	1.41%
Japan	1.24%
Sweden	1.2%
Netherlands	0.82%
Australia	0.62%
Denmark	0.57%
Liechtenstein	0.52%
Singapore	0.29%
South Korea	0.29%
Hong Kong	0.22%
Ireland	0.19%
Belgium	0.18%
Luxembourg	0.16%
Italy	0.15%
Brazil	0.12%
Individuals	0.12%
Austria	0.08%
Israel	0.08%
Finland	0.07%
Spain	0.07%
New Zealand	0.06%
Czech Republic	0.03%
Taiwan	0.01%
South Africa	0.01%
Mexico	0.01%
Slovenia	0.01%
Puerto Rico	0.01%
China	0.01%

Based on 1000 largest holdings

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (73.2%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - scientific analysis equipments (16.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.; - diagnostics equipment and products (10.1%). Net sales break down by source of revenue between sales of products (58.4%) and services (41.6%). Net sales break down geographically as follows: North America (52.5%), Europe (25.3%), Asia/Pacific (18.6%) and other (3.6%).

Employees

125,000

Sector

Advanced Medical Equipment & Technology

Calendar

Apr. 23 - Earnings release - Q1 2026

More about the company